Board Meetings for MARKSANS
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| MARKSANS | Marksans Pharma Limited | 08 Feb 2019 | Financial Results | To consider and approve the financial results for the period ended December 31, 2018 | |
| MARKSANS | Marksans Pharma Limited | 13 Nov 2018 | Financial Results | To consider and approve the financial results for the period ended September 30, 2018 | |
| MARKSANS | Marksans Pharma Limited | 06 Aug 2018 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 | |
| MARKSANS | Marksans Pharma Limited | 30 May 2018 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and recommendation of dividend if any. the Meeting of the Board of Directors of the Company will be held on Wednesday, 30th May, 2018 at Mumbai | |
| MARKSANS | Marksans Pharma Limited | 12 Feb 2018 | Results | To consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter ended on December 31,2017. | |
| MARKSANS | Marksans Pharma Limited | 13 Nov 2017 | Results | To consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended September 30, 2017. | |
| MARKSANS | Marksans Pharma Limited | 11 Aug 2017 | Results | inter alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended on June 30, 2017. | |
| MARKSANS | Marksans Pharma Limited | 29 May 2017 | Results/Dividend | To consider and approve the Annual Audited Financial Results of the Company (both Standalone and Consolidated) for the Financial Year ended March 31, 2017. The Board of Directors will also consider recommendation of dividend, if any, for the Financial Year 2016-17. | |
| MARKSANS | Marksans Pharma Limited | 06 Feb 2017 | Results | inter alia, to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Third Quarter ended on December 31, 2016. | |
| MARKSANS | Marksans Pharma Limited | 12 Nov 2016 | Results | Inter alia, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Second Quarter ended on September 30, 2016. | |
| MARKSANS | Marksans Pharma Limited | 13 Aug 2016 | Results | inter alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended on June 30, 2016. | |
| MARKSANS | Marksans Pharma Limited | 30 May 2016 | Results/Dividend | Inter alia, to consider and approve Audited Financial Results of the Company for the financial year ended March 31, 2016 and to consider recommendation of dividend, if any, for the financial year ended March 31, 2016. | |
| MARKSANS | Marksans Pharma Limited | 12 Feb 2016 | Results | inter alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended on 31st December, 2015. | |
| MARKSANS | Marksans Pharma Limited | 10 Nov 2015 | Results | inter alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended on September 30, 2015. | |
| MARKSANS | Marksans Pharma Limited | 08 Aug 2015 | Results | Inter-alia, to consider and approve Unaudited Financial Results of the Company for the Quarter ended 30th June, 2015. |